Other than these genes, miRNA level alteration, like miR-33a, -27b, miR-298, miR-1246, miR-3130 and miR-584, and epigenetic alteration, like CTCF hypermethylation and histone3 acetylation, led to drug resistance in BC patients. This evidence concerns the gene CTCF and breast cancer.